BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17994118)

  • 1. Allogeneic transplantation for childhood ALL.
    Mehta PA; Davies SM
    Bone Marrow Transplant; 2008 Jan; 41(2):133-9. PubMed ID: 17994118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.
    Bachanova V; Weisdorf D
    Bone Marrow Transplant; 2008 Mar; 41(5):455-64. PubMed ID: 17968329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of transplantation regimen on prognostic significance of high-level minimal residual disease before allogeneic stem cell transplantation in children with ALL.
    Schneider M; Hettinger K; Matthes-Martin S; Konrad M; Peters C; Gadner H; Panzer-Grümayer ER
    Bone Marrow Transplant; 2001 Dec; 28(11):1087-9. PubMed ID: 11781621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hemopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission-similar outcomes after matched related and unrelated donor transplant: a study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon).
    Muñoz A; Diaz-Heredia C; Diaz MA; Badell I; Verdeguer A; Martinez A; Gomez P; Perez-Hurtado JM; Bureo E; Fernandez-Delgado R; Gonzalez-Valentin ME; Maldonado MS
    Pediatr Hematol Oncol; 2008 Jun; 25(4):245-59. PubMed ID: 18484470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
    Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
    Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double allogeneic peripheral blood stem cell transplantation in a 9-year-old patient with relapsed acute lymphoblastic leukemia: case report.
    Fujii H; Goto H; Watanabe Y; Yamazaki S; Takahashi H; Sekiguchi H; Funabiki T; Ikuta K; Yokota S
    Pediatr Hematol Oncol; 2004; 21(3):261-5. PubMed ID: 15202165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a meta-analysis.
    Bartolozzi B; Bosi A; Orsi C
    Cancer; 2007 Jan; 109(2):343; author reply 344. PubMed ID: 17154182
    [No Abstract]   [Full Text] [Related]  

  • 9. Stem cell transplantation for pediatric lymphoma: past, present and future.
    Bradley MB; Cairo MS
    Bone Marrow Transplant; 2008 Jan; 41(2):149-58. PubMed ID: 18084337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-intensity allografting in childhood acute lymphoblastic leukemia.
    Ruiz-Delgado GJ; Rodriguez-Romo L; Tarin-Arzaga LC; Lutz-Presno J; Gomez-Almaguer D; Ruiz-Arguelles GJ
    Biol Blood Marrow Transplant; 2011 Mar; 17(3):439-40. PubMed ID: 21172448
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
    J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic SCT in children with ALL: current concepts of ongoing prospective SCT trials.
    Schrauder A; von Stackelberg A; Schrappe M; Cornish J; Peters C; ; ;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S71-4. PubMed ID: 18545248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic transplantation for ALL in adults.
    Stein A; Forman SJ
    Bone Marrow Transplant; 2008 Mar; 41(5):439-46. PubMed ID: 18334992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous and allogeneic stem cell transplantation in Hodgkin's lymphoma.
    Sureda A
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):943-60. PubMed ID: 17908630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic SCT in refractory or relapsed adult ALL is effective without prior reinduction chemotherapy.
    Terwey TH; Massenkeil G; Tamm I; Hemmati PG; Neuburger S; Martus P; Dörken B; Hoelzer D; Arnold R
    Bone Marrow Transplant; 2008 Dec; 42(12):791-8. PubMed ID: 18711350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of childhood acute lymphoblastic leukemia.
    Stanulla M; Schrappe M
    Semin Hematol; 2009 Jan; 46(1):52-63. PubMed ID: 19100368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of MRD in children undergoing allogeneic stem cell transplantation for ALL.
    Goulden N; Steward C
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):59-70. PubMed ID: 11987916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the outcomes of children with acute myelogenous leukemia in either first or second complete remission (CR1 vs CR2) following allogeneic hematopoietic stem cell transplantation at a single transplant center.
    Gassas A; Ishaqi MK; Afzal S; Finkelstein-Shechter T; Dupuis A; Doyle J
    Bone Marrow Transplant; 2008 Jun; 41(11):941-5. PubMed ID: 18264141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of isolated central nervous system relapse in high-risk lymphoid malignancy with allogeneic bone marrow transplantation and extended intrathecal therapy.
    Nagatoshi Y; Kawano Y; Nagayama J; Okamura J
    Br J Haematol; 2004 Jun; 125(6):766-8. PubMed ID: 15180866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.
    Spreafico F; Bisogno G; Collini P; Jenkner A; Gandola L; D'Angelo P; Casazza G; Piva L; Luksch R; Perotti D; Pession A; Fagioli F; Dallorso S
    Pediatr Blood Cancer; 2008 Jul; 51(1):23-8. PubMed ID: 18293386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.